Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Action Potentials | 39 | 2025 | 246 | 9.890 |
Why?
|
| Neurons | 39 | 2025 | 1246 | 7.710 |
Why?
|
| Models, Neurological | 21 | 2025 | 135 | 6.660 |
Why?
|
| Globus Pallidus | 12 | 2025 | 20 | 5.450 |
Why?
|
| Corpus Striatum | 16 | 2024 | 119 | 4.260 |
Why?
|
| Interneurons | 13 | 2020 | 64 | 3.650 |
Why?
|
| Subthalamic Nucleus | 11 | 2023 | 15 | 3.460 |
Why?
|
| Nerve Net | 10 | 2025 | 96 | 2.930 |
Why?
|
| Biological Clocks | 8 | 2020 | 52 | 2.480 |
Why?
|
| Synapses | 8 | 2024 | 184 | 1.960 |
Why?
|
| Electrophysiological Phenomena | 5 | 2021 | 20 | 1.800 |
Why?
|
| Inhibitory Postsynaptic Potentials | 4 | 2024 | 12 | 1.570 |
Why?
|
| Neural Pathways | 8 | 2024 | 139 | 1.520 |
Why?
|
| Neural Inhibition | 8 | 2020 | 48 | 1.500 |
Why?
|
| Animals | 57 | 2025 | 16695 | 1.440 |
Why?
|
| Neostriatum | 6 | 2012 | 28 | 1.380 |
Why?
|
| Membrane Potentials | 9 | 2014 | 221 | 1.310 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2012 | 80 | 1.220 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2016 | 1737 | 0.960 |
Why?
|
| Mice | 17 | 2024 | 6490 | 0.890 |
Why?
|
| Rats | 25 | 2014 | 3701 | 0.850 |
Why?
|
| Patch-Clamp Techniques | 13 | 2019 | 228 | 0.840 |
Why?
|
| Computer Simulation | 9 | 2025 | 404 | 0.790 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 658 | 0.770 |
Why?
|
| Periodicity | 5 | 2017 | 34 | 0.730 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 4 | 2009 | 8 | 0.680 |
Why?
|
| Acetylcholine | 5 | 2009 | 76 | 0.660 |
Why?
|
| Oscillometry | 2 | 2018 | 9 | 0.650 |
Why?
|
| Synaptic Transmission | 8 | 2012 | 156 | 0.640 |
Why?
|
| Mesencephalon | 4 | 2023 | 42 | 0.600 |
Why?
|
| Models, Statistical | 3 | 2014 | 190 | 0.540 |
Why?
|
| Adaptation, Physiological | 3 | 2009 | 135 | 0.540 |
Why?
|
| Dopamine | 7 | 2011 | 272 | 0.540 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2007 | 81 | 0.540 |
Why?
|
| Calcium | 4 | 2009 | 487 | 0.540 |
Why?
|
| Apamin | 5 | 2009 | 8 | 0.520 |
Why?
|
| Male | 23 | 2024 | 22779 | 0.520 |
Why?
|
| Female | 21 | 2024 | 24018 | 0.470 |
Why?
|
| Parvalbumins | 4 | 2023 | 17 | 0.470 |
Why?
|
| Calcium Channels | 5 | 2012 | 74 | 0.460 |
Why?
|
| Cerebral Cortex | 3 | 2016 | 303 | 0.450 |
Why?
|
| Afferent Pathways | 1 | 2014 | 43 | 0.440 |
Why?
|
| Biophysical Phenomena | 2 | 2011 | 22 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 1804 | 0.440 |
Why?
|
| Cell Membrane | 3 | 2010 | 400 | 0.410 |
Why?
|
| Electrical Synapses | 1 | 2013 | 3 | 0.410 |
Why?
|
| Differential Threshold | 2 | 2010 | 5 | 0.400 |
Why?
|
| Electric Stimulation | 7 | 2024 | 198 | 0.400 |
Why?
|
| Tissue Culture Techniques | 3 | 2017 | 36 | 0.390 |
Why?
|
| Locomotion | 1 | 2013 | 104 | 0.380 |
Why?
|
| Nonlinear Dynamics | 2 | 2009 | 35 | 0.370 |
Why?
|
| Animals, Newborn | 6 | 2011 | 350 | 0.370 |
Why?
|
| Synaptic Potentials | 2 | 2023 | 8 | 0.370 |
Why?
|
| Axons | 2 | 2023 | 116 | 0.350 |
Why?
|
| Potassium Channels, Calcium-Activated | 3 | 2005 | 7 | 0.350 |
Why?
|
| Organ Culture Techniques | 4 | 2020 | 102 | 0.330 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2007 | 83 | 0.320 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 67 | 0.320 |
Why?
|
| Cluster Analysis | 1 | 2010 | 206 | 0.310 |
Why?
|
| Dendrites | 2 | 2006 | 57 | 0.310 |
Why?
|
| Ion Channels | 1 | 2009 | 74 | 0.300 |
Why?
|
| Cholinergic Fibers | 2 | 2005 | 10 | 0.290 |
Why?
|
| Basal Ganglia | 2 | 2023 | 20 | 0.290 |
Why?
|
| Algorithms | 5 | 2013 | 508 | 0.280 |
Why?
|
| Linear Models | 3 | 2017 | 311 | 0.280 |
Why?
|
| Calcium Signaling | 2 | 2005 | 108 | 0.270 |
Why?
|
| Calcium Channel Blockers | 5 | 2009 | 57 | 0.270 |
Why?
|
| Time Factors | 6 | 2011 | 1848 | 0.260 |
Why?
|
| Cortical Synchronization | 1 | 2006 | 3 | 0.260 |
Why?
|
| Models, Biological | 2 | 2010 | 711 | 0.250 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2006 | 9 | 0.250 |
Why?
|
| Biophysics | 3 | 2011 | 38 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2009 | 133 | 0.240 |
Why?
|
| Presynaptic Terminals | 1 | 2006 | 54 | 0.240 |
Why?
|
| Potassium Channel Blockers | 4 | 2011 | 34 | 0.240 |
Why?
|
| Acetylcholinesterase | 1 | 2005 | 55 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2023 | 88 | 0.230 |
Why?
|
| Sensory Thresholds | 1 | 2004 | 13 | 0.220 |
Why?
|
| Neurochemistry | 1 | 2004 | 6 | 0.220 |
Why?
|
| Somatosensory Cortex | 1 | 2004 | 24 | 0.220 |
Why?
|
| Neurophysiology | 1 | 2004 | 10 | 0.220 |
Why?
|
| Vibrissae | 1 | 2004 | 32 | 0.220 |
Why?
|
| Neuroanatomy | 1 | 2004 | 7 | 0.220 |
Why?
|
| Tetrodotoxin | 3 | 2009 | 23 | 0.220 |
Why?
|
| Sodium Channel Blockers | 3 | 2009 | 18 | 0.210 |
Why?
|
| Staining and Labeling | 1 | 2004 | 106 | 0.210 |
Why?
|
| Lysine | 1 | 2004 | 120 | 0.210 |
Why?
|
| Blood Coagulation Disorders | 1 | 2023 | 8 | 0.200 |
Why?
|
| Hemostatics | 1 | 2023 | 10 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 2 | 2023 | 382 | 0.200 |
Why?
|
| Nurses | 1 | 2023 | 55 | 0.200 |
Why?
|
| Feedback | 3 | 2007 | 55 | 0.190 |
Why?
|
| Ion Channel Gating | 2 | 2010 | 81 | 0.160 |
Why?
|
| Sodium | 2 | 2009 | 101 | 0.150 |
Why?
|
| Tetraethylammonium | 2 | 2011 | 6 | 0.150 |
Why?
|
| Sodium Channels | 2 | 2012 | 66 | 0.140 |
Why?
|
| Brain | 1 | 2006 | 1452 | 0.140 |
Why?
|
| Corpus Callosum | 1 | 2018 | 14 | 0.140 |
Why?
|
| Motor Activity | 1 | 2021 | 438 | 0.140 |
Why?
|
| Potassium Channels | 2 | 2012 | 81 | 0.140 |
Why?
|
| Auditory Cortex | 1 | 2018 | 14 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2014 | 1617 | 0.130 |
Why?
|
| omega-Conotoxin GVIA | 2 | 2009 | 6 | 0.130 |
Why?
|
| Photic Stimulation | 1 | 2017 | 123 | 0.130 |
Why?
|
| Kinetics | 3 | 2016 | 698 | 0.120 |
Why?
|
| GABA Antagonists | 2 | 2012 | 29 | 0.120 |
Why?
|
| Pyramidal Cells | 2 | 2006 | 65 | 0.110 |
Why?
|
| Beta Rhythm | 1 | 2014 | 2 | 0.110 |
Why?
|
| Electric Impedance | 1 | 2014 | 28 | 0.110 |
Why?
|
| Organ Specificity | 1 | 2014 | 141 | 0.110 |
Why?
|
| Electrophysiology | 2 | 2004 | 138 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2013 | 45 | 0.100 |
Why?
|
| Humans | 14 | 2023 | 42163 | 0.100 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2012 | 93 | 0.100 |
Why?
|
| Corneal Diseases | 2 | 1986 | 11 | 0.090 |
Why?
|
| Elapid Venoms | 1 | 2011 | 16 | 0.090 |
Why?
|
| Organic Chemicals | 1 | 2011 | 35 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2010 | 8 | 0.080 |
Why?
|
| Receptors, GABA | 1 | 2010 | 28 | 0.080 |
Why?
|
| Receptors, AMPA | 2 | 2010 | 57 | 0.080 |
Why?
|
| Shal Potassium Channels | 1 | 2009 | 2 | 0.080 |
Why?
|
| Fura-2 | 1 | 2009 | 13 | 0.080 |
Why?
|
| Glutamate Decarboxylase | 1 | 2009 | 17 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 113 | 0.080 |
Why?
|
| Poisson Distribution | 1 | 2009 | 44 | 0.080 |
Why?
|
| Potassium | 1 | 2009 | 109 | 0.070 |
Why?
|
| Software | 1 | 2010 | 234 | 0.070 |
Why?
|
| Calcium Channels, N-Type | 1 | 2007 | 6 | 0.070 |
Why?
|
| Vitreous Body | 1 | 1986 | 11 | 0.060 |
Why?
|
| Ovariectomy | 1 | 1987 | 128 | 0.060 |
Why?
|
| Laser Therapy | 1 | 1986 | 25 | 0.060 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 1986 | 36 | 0.060 |
Why?
|
| RGS Proteins | 1 | 2006 | 6 | 0.060 |
Why?
|
| Dendritic Spines | 1 | 2007 | 35 | 0.060 |
Why?
|
| Gene Expression | 1 | 2009 | 692 | 0.060 |
Why?
|
| Bone and Bones | 1 | 1987 | 115 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1987 | 246 | 0.060 |
Why?
|
| Cesium | 1 | 2005 | 8 | 0.060 |
Why?
|
| Barium | 1 | 2005 | 16 | 0.060 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1985 | 2 | 0.060 |
Why?
|
| Parenteral Nutrition | 1 | 1985 | 15 | 0.060 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1985 | 35 | 0.060 |
Why?
|
| Thalamus | 1 | 2004 | 34 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 37 | 0.050 |
Why?
|
| Parkinson Disease | 2 | 2006 | 207 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2005 | 126 | 0.050 |
Why?
|
| Biotin | 1 | 2004 | 24 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2004 | 36 | 0.050 |
Why?
|
| Electrochemistry | 1 | 2004 | 38 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2004 | 108 | 0.050 |
Why?
|
| Electrodes | 1 | 2004 | 57 | 0.050 |
Why?
|
| Neural Conduction | 1 | 2003 | 17 | 0.050 |
Why?
|
| Energy Intake | 1 | 1985 | 162 | 0.050 |
Why?
|
| Nifedipine | 1 | 2003 | 11 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2005 | 130 | 0.050 |
Why?
|
| Equipment Design | 1 | 2004 | 143 | 0.050 |
Why?
|
| Thrombelastography | 1 | 2023 | 4 | 0.050 |
Why?
|
| Critical Care | 1 | 2023 | 48 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2002 | 30 | 0.050 |
Why?
|
| Receptors, Nicotinic | 1 | 2002 | 114 | 0.050 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2021 | 1 | 0.040 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2021 | 13 | 0.040 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2021 | 369 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 65 | 0.030 |
Why?
|
| Transfection | 1 | 2018 | 526 | 0.030 |
Why?
|
| Allantoin | 1 | 1986 | 1 | 0.030 |
Why?
|
| Caffeine | 1 | 1986 | 28 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 847 | 0.030 |
Why?
|
| Liver | 1 | 1986 | 503 | 0.020 |
Why?
|
| Iontophoresis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Picrotoxin | 1 | 2010 | 14 | 0.020 |
Why?
|
| Isonicotinic Acids | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptors, GABA-B | 1 | 2010 | 11 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2010 | 21 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1970 | 35 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 126 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2010 | 65 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2010 | 90 | 0.020 |
Why?
|
| Sulpiride | 1 | 2007 | 6 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 39 | 0.020 |
Why?
|
| Quinpirole | 1 | 2007 | 18 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2007 | 48 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2007 | 34 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2007 | 151 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 1987 | 64 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 1987 | 74 | 0.020 |
Why?
|
| Minerals | 1 | 1987 | 52 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 1987 | 44 | 0.020 |
Why?
|
| Oxotremorine | 1 | 2006 | 1 | 0.020 |
Why?
|
| Autoreceptors | 1 | 2006 | 2 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2006 | 10 | 0.020 |
Why?
|
| Eye Diseases | 1 | 1986 | 26 | 0.020 |
Why?
|
| Cell Communication | 1 | 2006 | 110 | 0.010 |
Why?
|
| Food, Formulated | 1 | 1985 | 4 | 0.010 |
Why?
|
| Nutritional Requirements | 1 | 1985 | 33 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1986 | 253 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 452 | 0.010 |
Why?
|
| Gastric Juice | 1 | 1974 | 3 | 0.010 |
Why?
|
| Pentagastrin | 1 | 1974 | 2 | 0.010 |
Why?
|
| Ion Transport | 1 | 2003 | 22 | 0.010 |
Why?
|
| Calcium Channels, L-Type | 1 | 2003 | 20 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 534 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2002 | 44 | 0.010 |
Why?
|
| Heart Rate | 1 | 1974 | 261 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1066 | 0.010 |
Why?
|
| Addison Disease | 1 | 1972 | 1 | 0.010 |
Why?
|
| Anemia, Pernicious | 1 | 1972 | 1 | 0.010 |
Why?
|
| Vitiligo | 1 | 1972 | 3 | 0.010 |
Why?
|
| Graves Disease | 1 | 1972 | 3 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1972 | 25 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1985 | 960 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1972 | 42 | 0.010 |
Why?
|
| Infant | 1 | 1985 | 1143 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1972 | 99 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1985 | 1516 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1974 | 662 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 2111 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1986 | 14 | 0.010 |
Why?
|
| Child | 1 | 1985 | 3381 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1986 | 39 | 0.010 |
Why?
|
| Biotransformation | 1 | 1986 | 68 | 0.010 |
Why?
|
| Endothelium | 1 | 1985 | 28 | 0.010 |
Why?
|
| Phosphoric Acids | 1 | 1970 | 2 | 0.010 |
Why?
|
| Pentosephosphates | 1 | 1970 | 4 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1970 | 6 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1970 | 33 | 0.010 |
Why?
|
| Phosphates | 1 | 1970 | 54 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 1970 | 40 | 0.000 |
Why?
|
| Magnesium | 1 | 1970 | 93 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1970 | 189 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1970 | 141 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1970 | 205 | 0.000 |
Why?
|
| Models, Chemical | 1 | 1970 | 205 | 0.000 |
Why?
|
| Adult | 3 | 1985 | 13458 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1974 | 21 | 0.000 |
Why?
|
| Gastric Mucosa | 1 | 1974 | 64 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1972 | 3 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1972 | 64 | 0.000 |
Why?
|
| Antibodies | 1 | 1972 | 140 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1972 | 236 | 0.000 |
Why?
|
| Hypertension | 1 | 1974 | 823 | 0.000 |
Why?
|